InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,509.01
(
0.62%
)
US TECH 100
19,460.00
(
0.95%
)
Dow Jones
39,331.85
(
0.41%
)
Brent Oil
86.49
(
0.05%
)
Bitcoin
60,960.02
(
-1.72%
)
Post# of 438
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DanWebzster

Send PM Follow Ignore
Followers 10
Posts 1060
Boards Moderated 2
Alias Born 09/04/2000

DanWebzster

Member Level

Re: DanWebzster post# 4

Wednesday, 09/12/2018 12:37:47 PM

Wednesday, September 12, 2018 12:37:47 PM

Post# of 438
FOLD ( update )

Pompe program was set back by FDA refusal to grant accelerated review status

More clinical data is due in the Pompe program during Q4/18

Commercial efforts for the Fabry program are going reasonably well and they raised revenue guidance for the rest of the year.

Cash runway is at least thru 2020; but, FOLD has a history of raising capital whenever they can.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up